Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial

Peto TJ., Tripura R., Callery JJ., Lek D., Nghia HDT., Nguon C., Thuong NTH., van der Pluijm RW., Dung NTP., Sokha M., Van Luong V., Long LT., Sovann Y., Duanguppama J., Waithira N., Hoglund RM., Chotsiri P., Chau NH., Ruecker A., Amaratunga C., Dhorda M., Miotto O., Maude RJ., Rekol H., Chotivanich K., Tarning J., von Seidlein L., Imwong M., Mukaka M., Day NPJ., Hien TT., White NJ., Dondorp AM.

DOI

10.1016/s1473-3099(21)00692-7

Type

Journal article

Journal

The Lancet Infectious Diseases

Publisher

Elsevier BV

Publication Date

03/2022

Permalink Original publication